Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
PLoS ONE - United States
doi 10.1371/journal.pone.0017745
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 17, 2011
Authors
Publisher
Public Library of Science (PLoS)